Literature DB >> 17328916

Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease.

Irena Martinić Popović1, Vesna Serić, Vida Demarin.   

Abstract

We tried to evaluate and to compare usefulness of two brief cognitive tests in early detection of cognitive decline in subjects with increased cerebrovascular (CV) risk. As CV risk factors are recognised as important in etiology of dementia, we also aimed to determine the possible associations of specific CV risk factors and cognitive results. Patients (PGs) with first-ever stroke or TIA (N=110) and CV symptoms-free controls (CGs) with CV risk factors present (N=45) matched for age, gender and education level were tested using Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) on admission, at three- and six-month points. In all subjects, detailed CV risk factors profile was assessed. We observed the decrement in cognitive performance during the six-month study period in both groups, more evident if MoCA (p<0.001) than if MMSE was used (p=0.022). Six months after first stroke/TIA 83.6% PGs scored below normal range on MoCA. In PGs, positive associations for cognitive decrement and multiple CV risk factors (>2) were found (p=0.034 for MMSE; p=0.002 for MoCA). In CGs, positive associations were found for cognitive decrement and arterial hypertension with increased IMT values (p<0.001 for MMSE) and for multiple CV risk factors and arterial hypertension (p=0.003 for MoCA). The use of MoCA could aid to early recognition of cognitive deficits in persons with increased CV risk. Individuals with multiple CV risk factors seem to have increased risk of cognitive decline.

Entities:  

Mesh:

Year:  2007        PMID: 17328916     DOI: 10.1016/j.jns.2007.01.029

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  31 in total

1.  Synergistic effects of age and stress in a rodent model of stroke.

Authors:  Dawn L Merrett; Scott W Kirkland; Gerlinde A Metz
Journal:  Behav Brain Res       Date:  2010-04-29       Impact factor: 3.332

2.  Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis?

Authors:  Tanya N Turan; Alison Smock; George Cotsonis; David Bachman; Sami Al Kasab; Michael J Lynn; Azhar Nizham; Collin P Derdeyn; David Fiorella; Scott Janis; Bethany Lane; Jean Montgomery; Marc I Chimowitz
Journal:  Cerebrovasc Dis       Date:  2016-11-05       Impact factor: 2.762

3.  Neuroimaging signatures and cognitive correlates of the montreal cognitive assessment screen in a nonclinical elderly sample.

Authors:  Robert Paul; Elizabeth M Lane; David F Tate; Jodi Heaps; Dana M Romo; Erbil Akbudak; Jennifer Niehoff; Thomas E Conturo
Journal:  Arch Clin Neuropsychol       Date:  2011-06-04       Impact factor: 2.813

4.  Analysis of cognitive dysfunction with silent cerebral infarction: a prospective study in Chinese patients.

Authors:  Jing Zhao; Huidong Tang; Jialan Sun; Baisong Wang; Shengdi Chen; Yi Fu
Journal:  Metab Brain Dis       Date:  2011-12-23       Impact factor: 3.584

5.  Performance-Based Contingency Management in Cognitive Remediation Training: A Pilot Study.

Authors:  Brian D Kiluk; Matthew B Buck; Kathleen A Devore; Theresa A Babuscio; Charla Nich; Kathleen M Carroll
Journal:  J Subst Abuse Treat       Date:  2016-08-10

6.  Normative Data for the Montreal Cognitive Assessment in Middle-Aged and Elderly Quebec-French People.

Authors:  Eddy Larouche; Marie-Pier Tremblay; Olivier Potvin; Sophie Laforest; David Bergeron; Robert Laforce; Laura Monetta; Linda Boucher; Pascale Tremblay; Sylvie Belleville; Dominique Lorrain; Jean-François Gagnon; Nadia Gosselin; Christian-Alexandre Castellano; Stephen C Cunnane; Joël Macoir; Carol Hudon
Journal:  Arch Clin Neuropsychol       Date:  2016-11-22       Impact factor: 2.813

7.  How predictive is the MMSE for cognitive performance after stroke?

Authors:  Ariane Bour; Sascha Rasquin; Anita Boreas; Martien Limburg; Frans Verhey
Journal:  J Neurol       Date:  2009-11-22       Impact factor: 4.849

8.  Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment.

Authors:  Emilia Salvadori; Marco Pasi; Anna Poggesi; Guido Chiti; Domenico Inzitari; Leonardo Pantoni
Journal:  J Neurol       Date:  2013-05-29       Impact factor: 4.849

9.  Validation studies of the Portuguese experimental version of the Montreal Cognitive Assessment (MoCA): confirmatory factor analysis.

Authors:  Diana Duro; Mário R Simões; Emanuel Ponciano; Isabel Santana
Journal:  J Neurol       Date:  2009-11-25       Impact factor: 4.849

10.  Rapid cognitive screening of patients with substance use disorders.

Authors:  Marc L Copersino; William Fals-Stewart; Garrett Fitzmaurice; David J Schretlen; Jody Sokoloff; Roger D Weiss
Journal:  Exp Clin Psychopharmacol       Date:  2009-10       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.